New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust efficacy and long-term prevention Read more
Key differences in gut bacterial compositions between Indian and Western populations due to fibre-rich diet Read more
Researchers from Tel Aviv University develop process that could reverse early signs of Alzheimer’s Read more
Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 treatment in virologically suppressed adults Read more
FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) Read more
Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine Read more